Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches
Purpose: Drug repurposing is an approach successfully used for discovery of new therapeutic applications for the existing drugs. The current study was aimed to use the combination of in silico methods to identify FDA-approved drugs with possible S1P1 agonistic activity useful in multiple sclerosis (...
Saved in:
Main Authors: | Ali Akbar Alizadeh (Author), Behzad Jafari (Author), Siavoush Dastmalchi (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
On the Integration of In Silico Drug Design Methods for Drug Repurposing
by: Eric March-Vila, et al.
Published: (2017) -
In silico Docking Studies of Fingolimod and S1P1 Agonists
by: Alexander Marciniak, et al.
Published: (2020) -
Computational Drug Repurposing Algorithm Targeting TRPA1 Calcium Channel as a Potential Therapeutic Solution for Multiple Sclerosis
by: Dragos Paul Mihai, et al.
Published: (2019) -
Identification of Novel Single Chain Fragment Variable Antibodies Against TNF-α Using Phage Display Technology
by: Ali Akbar Alizadeh, et al.
Published: (2015) -
Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies
by: Ashraf K. El-Damasy, et al.
Published: (2024)